FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136760939> ?p ?o ?g. }

• W3136760939 abstract "Abstract Background Lung adenocarcinoma (LUAD) is one of the most common malignancies worldwide. However, the molecular mechanism of LUAD tumorigenesis and development remains unclear. The purpose of this study was to comprehensively illustrate the role of GTF2E2 in the growth and progression of LUAD. Methods and materials We obtained the mRNA expression data from The Cancer Genome Atlas, Gene Expression Omnibus database, and our institution. Systematic bioinformatical analyses were performed to investigate the expression and prognostic value of GTF2E2 in LUAD. The results were validated by immunohistochemistry and qPCR. The effect of knocking down GTF2E2 using two short hairpin RNAs was investigated by in vitro and in vivo assays. Subsequently, shotgun liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) analyses were applied to identified potential GTF2E2 interacting proteins, and the downstream molecular mechanisms of GTF2E2-signaling were further explored by a series of cellular functional assays. Results We found that GTF2E2 expression was significantly increased in LUAD tissue compared with adjacent normal tissue and was negatively associated with patients’ overall survival. Besides, we demonstrated that GTF2E2 knockdown inhibited LUAD cell proliferation, migration, invasion, and promote apoptosis in vitro, as well as attenuated tumor growth in vivo. Results from LC–MS/MS suggested that RPS4X might physically interact with GTF2E2 and mediated GTF2E2’s regulatory effect on LUAD development through the mTOR pathway. Conclusion Our findings indicate that GTF2E2 promotes LUAD development by activating RPS4X. Therefore, GTF2E2 might serve as a promising biomarker for the diagnosis and prognosis of LUAD patients, thus shedding light on the precise and personalized therapy for LUAD in the future." @default.
• W3136760939 created "2021-03-29" @default.
• W3136760939 creator A5000196145 @default.
• W3136760939 creator A5034950647 @default.
• W3136760939 creator A5047703660 @default.
• W3136760939 creator A5049130282 @default.
• W3136760939 creator A5052095171 @default.
• W3136760939 creator A5054452431 @default.
• W3136760939 creator A5056442373 @default.
• W3136760939 date "2021-03-23" @default.
• W3136760939 modified "2023-10-17" @default.
• W3136760939 title "Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo" @default.
• W3136760939 cites W1995533874 @default.
• W3136760939 cites W2000743500 @default.
• W3136760939 cites W2005403381 @default.
• W3136760939 cites W2007539985 @default.
• W3136760939 cites W2007618989 @default.
• W3136760939 cites W2015408193 @default.
• W3136760939 cites W2017326170 @default.
• W3136760939 cites W2052780159 @default.
• W3136760939 cites W2062243699 @default.
• W3136760939 cites W2114744705 @default.
• W3136760939 cites W2132445485 @default.
• W3136760939 cites W2293531514 @default.
• W3136760939 cites W2301830708 @default.
• W3136760939 cites W2527905628 @default.
• W3136760939 cites W2556180876 @default.
• W3136760939 cites W2737207041 @default.
• W3136760939 cites W2753020299 @default.
• W3136760939 cites W2753985039 @default.
• W3136760939 cites W2764015132 @default.
• W3136760939 cites W2787553551 @default.
• W3136760939 cites W2888656441 @default.
• W3136760939 cites W2889646458 @default.
• W3136760939 cites W2895840084 @default.
• W3136760939 cites W2910873889 @default.
• W3136760939 cites W2911831872 @default.
• W3136760939 cites W2944023060 @default.
• W3136760939 cites W3005240107 @default.
• W3136760939 cites W3006485746 @default.
• W3136760939 cites W3011633258 @default.
• W3136760939 cites W3011747005 @default.
• W3136760939 cites W3016248999 @default.
• W3136760939 cites W3027626844 @default.
• W3136760939 doi "https://doi.org/10.1186/s12935-021-01878-z" @default.
• W3136760939 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7989205" @default.
• W3136760939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33757492" @default.
• W3136760939 hasPublicationYear "2021" @default.
• W3136760939 type Work @default.
• W3136760939 sameAs 3136760939 @default.
• W3136760939 citedByCount "9" @default.
• W3136760939 countsByYear W31367609392021 @default.
• W3136760939 countsByYear W31367609392022 @default.
• W3136760939 countsByYear W31367609392023 @default.
• W3136760939 crossrefType "journal-article" @default.
• W3136760939 hasAuthorship W3136760939A5000196145 @default.
• W3136760939 hasAuthorship W3136760939A5034950647 @default.
• W3136760939 hasAuthorship W3136760939A5047703660 @default.
• W3136760939 hasAuthorship W3136760939A5049130282 @default.
• W3136760939 hasAuthorship W3136760939A5052095171 @default.
• W3136760939 hasAuthorship W3136760939A5054452431 @default.
• W3136760939 hasAuthorship W3136760939A5056442373 @default.
• W3136760939 hasBestOaLocation W31367609391 @default.
• W3136760939 hasConcept C121608353 @default.
• W3136760939 hasConcept C142724271 @default.
• W3136760939 hasConcept C173396325 @default.
• W3136760939 hasConcept C190232843 @default.
• W3136760939 hasConcept C190283241 @default.
• W3136760939 hasConcept C202751555 @default.
• W3136760939 hasConcept C203014093 @default.
• W3136760939 hasConcept C204232928 @default.
• W3136760939 hasConcept C207001950 @default.
• W3136760939 hasConcept C2776256026 @default.
• W3136760939 hasConcept C2781182431 @default.
• W3136760939 hasConcept C502942594 @default.
• W3136760939 hasConcept C54355233 @default.
• W3136760939 hasConcept C555283112 @default.
• W3136760939 hasConcept C62478195 @default.
• W3136760939 hasConcept C71924100 @default.
• W3136760939 hasConcept C86554907 @default.
• W3136760939 hasConcept C86803240 @default.
• W3136760939 hasConcept C95444343 @default.
• W3136760939 hasConceptScore W3136760939C121608353 @default.
• W3136760939 hasConceptScore W3136760939C142724271 @default.
• W3136760939 hasConceptScore W3136760939C173396325 @default.
• W3136760939 hasConceptScore W3136760939C190232843 @default.
• W3136760939 hasConceptScore W3136760939C190283241 @default.
• W3136760939 hasConceptScore W3136760939C202751555 @default.
• W3136760939 hasConceptScore W3136760939C203014093 @default.
• W3136760939 hasConceptScore W3136760939C204232928 @default.
• W3136760939 hasConceptScore W3136760939C207001950 @default.
• W3136760939 hasConceptScore W3136760939C2776256026 @default.
• W3136760939 hasConceptScore W3136760939C2781182431 @default.
• W3136760939 hasConceptScore W3136760939C502942594 @default.
• W3136760939 hasConceptScore W3136760939C54355233 @default.
• W3136760939 hasConceptScore W3136760939C555283112 @default.
• W3136760939 hasConceptScore W3136760939C62478195 @default.
• W3136760939 hasConceptScore W3136760939C71924100 @default.
• W3136760939 hasConceptScore W3136760939C86554907 @default.
• W3136760939 hasConceptScore W3136760939C86803240 @default.

• next